Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Professor YIN Kejing's clinical experience in treating Meige's syndrome with four-penetrating Yangbai (GB14) combined with double-needle connection technique].

Created on 16 Sep 2026

Authors

Xiaoru Zhou, Ruihui Wang, Jing Liu, Yaming Xu

Published in

Zhongguo zhen jiu = Chinese acupuncture & moxibustion. Volume 46. Issue 9. Pages 1515-1520. Sep 12, 2026. Epub Jul 03, 2026.

Abstract

Meige's syndrome is a refractory disorder characterized mainly by dystonia of the eyelids, typically presenting as blepharospasm and difficulty in opening the eyes, and may be accompanied by involuntary facial muscle spasms, with a prolonged and recurrent course. Professor YIN Kejing believes that the main pathogenesis of Meige's syndrome is internal stirring of liver wind. Treatment should address both the root cause and manifestations, with calming the liver and extinguishing wind as the general therapeutic principle. Professor YIN innovatively proposes the concept of alternative communication of the meridians, and adopts characteristic techniques including four-penetrating Yangbai(GB14), the double-needle connection technique, and the White Tiger Shaking Its Head manipulation to unblock the meridians, relieve spasm, and regulate qi and blood. The therapeutic efficacy is definite, providing a new approach for the clinical treatment of this disorder.

PMID:
42744640
Bibliographic data and abstract were imported from PubMed on 16 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement